Literature DB >> 16946674

Fibrovascular organization in the vitreous following laser for ROP: implications for prognosis.

M Elizabeth Hartnett1, Janet R McColm.   

Abstract

PURPOSE: To study associations between surgical outcome and mean postmenstrual age (PMA) when fibrovascular organization is detected between vascular and avascular retina following laser for acute retinopathy of prematurity (ROP).
METHODS: PMA at the time of detection of fibrovascular organization was determined in infants who had laser treatment for stage 3 ROP. Retinal features abstracted from examination sheets included zone, stage, and clock hours of fibrovascular organization, PMA at the times of first surgery and diagnosis of fibrovascular organization, and outcomes (retinal attachment after one surgery and retinal attachment at follow-up). Statistical analyses were performed to compare categorical data (Mann-Whitney U test, t-test, Fisher exact test) and determine correlations (Spearman rank test).
RESULTS: Fibrovascular organization was diagnosed in 38/39 eyes that required surgery and 19/41 eyes that did not. In surgical eyes, older PMA at the time of detection of fibrovascular organization, zone II ROP, and stage 4 (versus stage 5) ROP were each associated with successful reattachment of the retina after one surgery and at the end of follow-up. PMA at diagnosis of fibrovascular organization was associated with zone, but not stage, of ROP when surgical intervention was performed.
CONCLUSION: Fibrovascular organization between the vascular and avascular retina is important because it is associated with the development of retinal detachment after laser for acute ROP. Further study is required to determine if improved detection of fibrovascular organization in eyes of infants of early PMA will improve surgical outcomes for retinal detachment.

Entities:  

Mesh:

Year:  2006        PMID: 16946674      PMCID: PMC1828042          DOI: 10.1097/01.iae.0000244286.56133.09

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

Authors: 
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

2.  Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial.

Authors:  Alistair R Fielder
Journal:  Arch Ophthalmol       Date:  2003-12

3.  An international classification of retinopathy of prematurity. The Committee for the Classification of Retinopathy of Prematurity.

Authors: 
Journal:  Arch Ophthalmol       Date:  1984-08

4.  Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.

Authors:  Jonathan L Prenner; Antonio Capone; Michael T Trese
Journal:  Ophthalmology       Date:  2004-12       Impact factor: 12.079

5.  Lens-sparing vitrectomy for stage 4 retinopathy of prematurity.

Authors:  G Baker Hubbard; D Hunter Cherwick; Gabriela Burian
Journal:  Ophthalmology       Date:  2004-12       Impact factor: 12.079

6.  Pegaptanib for neovascular age-related macular degeneration.

Authors:  Evangelos S Gragoudas; Anthony P Adamis; Emmett T Cunningham; Matthew Feinsod; David R Guyer
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

7.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12

8.  Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors:  D B Schaffer; E A Palmer; D F Plotsky; H S Metz; J T Flynn; B Tung; R J Hardy
Journal:  Ophthalmology       Date:  1993-02       Impact factor: 12.079

9.  Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Retina       Date:  2003-06       Impact factor: 4.256

10.  Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1/2 years after randomization.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-04
View more
  6 in total

1.  Minimally fibrotic stage 5 ROP: a clinical prognostic factor in eyes undergoing vitrectomy for stage 5 retinopathy of prematurity.

Authors:  Salil S Gadkari; Madan Deshpande; Sucheta Kulkarni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-27       Impact factor: 3.117

2.  Insights into advanced retinopathy of prematurity using handheld spectral domain optical coherence tomography imaging.

Authors:  Sai H Chavala; Sina Farsiu; Ramiro Maldonado; David K Wallace; Sharon F Freedman; Cynthia A Toth
Journal:  Ophthalmology       Date:  2009-09-18       Impact factor: 12.079

3.  A review of treatment for retinopathy of prematurity.

Authors:  Eric D Hansen; M Elizabeth Hartnett
Journal:  Expert Rev Ophthalmol       Date:  2019-03-29

4.  Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.

Authors:  Parag K Shah; Minu Ramakrishnan; Bani Sadat; Sandeep Bachu; V Narendran; N Kalpana
Journal:  Oman J Ophthalmol       Date:  2014-09

5.  Posterior pole sparing laser photocoagulation combined with intravitreal bevacizumab injection in posterior retinopathy of prematurity.

Authors:  Rebecca Kim; Yu Cheol Kim
Journal:  J Ophthalmol       Date:  2014-12-28       Impact factor: 1.909

6.  Variation in the vitreoretinal configuration of Stage 4 retinopathy of prematurity in photocoagulated and treatment naive eyes undergoing vitrectomy.

Authors:  Salil Sharad Gadkari; Madan Deshpande
Journal:  Indian J Ophthalmol       Date:  2017-09       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.